二氧化硅诱导的肺纤维化:纤维化基因特征、途径和治疗机会。

IF 1.8 4区 医学 Q3 ALLERGY
Fahad Alsohime, Narjes Saheb Sharif-Askari, Nasser Saleh Alharbi, Mohammed Faraj Ayad Alosaimi, Rabih Halwani
{"title":"二氧化硅诱导的肺纤维化:纤维化基因特征、途径和治疗机会。","authors":"Fahad Alsohime, Narjes Saheb Sharif-Askari, Nasser Saleh Alharbi, Mohammed Faraj Ayad Alosaimi, Rabih Halwani","doi":"10.1159/000548097","DOIUrl":null,"url":null,"abstract":"<p><p>Silica exposure is a significant environmental hazard linked to lung inflammation and fibrosis. This study utilized in-silico analysis of publicly available transcriptomic datasets (GSE250537 and GSE142446) from silica-exposed Fischer 344 rats to investigate molecular pathways and potential therapeutic targets. Rats were exposed to crystalline silica via inhalation, and transcriptomic data from lung and blood samples were analyzed at four post-exposure intervals (1-day, 3-month, 6-month, and 9-month). Gene set enrichment analysis (GSEA) revealed the activation of fibro-inflammatory and aging pathways in lung tissue, including TGF-beta, NLRP3, and TNF-α signaling, with limited effects in blood transcriptomes. Differential expression analysis identified 12 key fibrotic markers consistently upregulated in lung tissue, such as Cxcl6, Mmp12, and S100a9, which are involved in inflammation, tissue remodeling, and fibrosis. Temporal analysis indicated prolonged upregulation of fibrotic markers up to 9 months post-exposure. Protein-protein interaction networks highlighted clusters related to chemokine signaling, tissue remodeling, and matrix metalloproteinases. Using the open-TG gate database, 179 pharmacological agents were identified as potential treatments, with 37 targeting five or more fibrotic genes. Notable candidates include NSAIDs, captopril, and simvastatin, offering promising therapeutic avenues to mitigate silica-induced lung pathology. In vivo validation in a silica-induced murine fibrosis model further demonstrated that simvastatin treatment significantly reduced the expression of key fibro-inflammatory genes and attenuated the increase in fibrotic markers in lung tissue. These findings provide insights into silica immunopathology and potential drug repurposing strategies; however, further studies are warranted to elucidate underlying mechanisms and evaluate therapeutic efficacy in clinical settings.</p>","PeriodicalId":13652,"journal":{"name":"International Archives of Allergy and Immunology","volume":" ","pages":"1-20"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Insights into Silica-Induced Lung Fibrosis: Fibrotic Gene Signatures, Pathways, and Therapeutic Opportunities.\",\"authors\":\"Fahad Alsohime, Narjes Saheb Sharif-Askari, Nasser Saleh Alharbi, Mohammed Faraj Ayad Alosaimi, Rabih Halwani\",\"doi\":\"10.1159/000548097\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Silica exposure is a significant environmental hazard linked to lung inflammation and fibrosis. This study utilized in-silico analysis of publicly available transcriptomic datasets (GSE250537 and GSE142446) from silica-exposed Fischer 344 rats to investigate molecular pathways and potential therapeutic targets. Rats were exposed to crystalline silica via inhalation, and transcriptomic data from lung and blood samples were analyzed at four post-exposure intervals (1-day, 3-month, 6-month, and 9-month). Gene set enrichment analysis (GSEA) revealed the activation of fibro-inflammatory and aging pathways in lung tissue, including TGF-beta, NLRP3, and TNF-α signaling, with limited effects in blood transcriptomes. Differential expression analysis identified 12 key fibrotic markers consistently upregulated in lung tissue, such as Cxcl6, Mmp12, and S100a9, which are involved in inflammation, tissue remodeling, and fibrosis. Temporal analysis indicated prolonged upregulation of fibrotic markers up to 9 months post-exposure. Protein-protein interaction networks highlighted clusters related to chemokine signaling, tissue remodeling, and matrix metalloproteinases. Using the open-TG gate database, 179 pharmacological agents were identified as potential treatments, with 37 targeting five or more fibrotic genes. Notable candidates include NSAIDs, captopril, and simvastatin, offering promising therapeutic avenues to mitigate silica-induced lung pathology. In vivo validation in a silica-induced murine fibrosis model further demonstrated that simvastatin treatment significantly reduced the expression of key fibro-inflammatory genes and attenuated the increase in fibrotic markers in lung tissue. These findings provide insights into silica immunopathology and potential drug repurposing strategies; however, further studies are warranted to elucidate underlying mechanisms and evaluate therapeutic efficacy in clinical settings.</p>\",\"PeriodicalId\":13652,\"journal\":{\"name\":\"International Archives of Allergy and Immunology\",\"volume\":\" \",\"pages\":\"1-20\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Archives of Allergy and Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000548097\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Archives of Allergy and Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000548097","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

摘要

二氧化硅暴露是一种与肺部炎症和纤维化有关的重大环境危害。本研究利用公开的硅暴露Fischer 344大鼠转录组数据集(GSE250537和GSE142446)的计算机分析来研究分子途径和潜在的治疗靶点。大鼠通过吸入暴露于结晶二氧化硅中,并在暴露后的四个时间间隔(1天、3个月、6个月和9个月)分析肺和血液样本的转录组数据。基因集富集分析(GSEA)揭示了肺组织中纤维炎症和衰老途径的激活,包括tgf - β、NLRP3和TNF-α信号,但对血液转录组的影响有限。差异表达分析发现,在肺组织中有12个关键的纤维化标志物持续上调,如Cxcl6、Mmp12和S100a9,这些标志物参与炎症、组织重塑和纤维化。时间分析表明,在暴露后9个月,纤维化标志物的上调时间延长。蛋白质相互作用网络突出了与趋化因子信号、组织重塑和基质金属蛋白酶相关的簇。利用开放的tg gate数据库,179种药物被确定为潜在的治疗药物,其中37种靶向5种或更多的纤维化基因。值得注意的候选药物包括非甾体抗炎药、卡托普利和辛伐他汀,它们为减轻二氧化硅引起的肺部病理提供了有希望的治疗途径。二氧化硅诱导的小鼠纤维化模型的体内验证进一步表明,辛伐他汀治疗显著降低了肺组织中关键纤维炎症基因的表达,并减弱了纤维化标志物的增加。这些发现为二氧化硅免疫病理学和潜在的药物再利用策略提供了见解;然而,需要进一步的研究来阐明潜在的机制并评估临床环境中的治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Insights into Silica-Induced Lung Fibrosis: Fibrotic Gene Signatures, Pathways, and Therapeutic Opportunities.

Silica exposure is a significant environmental hazard linked to lung inflammation and fibrosis. This study utilized in-silico analysis of publicly available transcriptomic datasets (GSE250537 and GSE142446) from silica-exposed Fischer 344 rats to investigate molecular pathways and potential therapeutic targets. Rats were exposed to crystalline silica via inhalation, and transcriptomic data from lung and blood samples were analyzed at four post-exposure intervals (1-day, 3-month, 6-month, and 9-month). Gene set enrichment analysis (GSEA) revealed the activation of fibro-inflammatory and aging pathways in lung tissue, including TGF-beta, NLRP3, and TNF-α signaling, with limited effects in blood transcriptomes. Differential expression analysis identified 12 key fibrotic markers consistently upregulated in lung tissue, such as Cxcl6, Mmp12, and S100a9, which are involved in inflammation, tissue remodeling, and fibrosis. Temporal analysis indicated prolonged upregulation of fibrotic markers up to 9 months post-exposure. Protein-protein interaction networks highlighted clusters related to chemokine signaling, tissue remodeling, and matrix metalloproteinases. Using the open-TG gate database, 179 pharmacological agents were identified as potential treatments, with 37 targeting five or more fibrotic genes. Notable candidates include NSAIDs, captopril, and simvastatin, offering promising therapeutic avenues to mitigate silica-induced lung pathology. In vivo validation in a silica-induced murine fibrosis model further demonstrated that simvastatin treatment significantly reduced the expression of key fibro-inflammatory genes and attenuated the increase in fibrotic markers in lung tissue. These findings provide insights into silica immunopathology and potential drug repurposing strategies; however, further studies are warranted to elucidate underlying mechanisms and evaluate therapeutic efficacy in clinical settings.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.60
自引率
3.60%
发文量
105
审稿时长
2 months
期刊介绍: ''International Archives of Allergy and Immunology'' provides a forum for basic and clinical research in modern molecular and cellular allergology and immunology. Appearing monthly, the journal publishes original work in the fields of allergy, immunopathology, immunogenetics, immunopharmacology, immunoendocrinology, tumor immunology, mucosal immunity, transplantation and immunology of infectious and connective tissue diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信